Financial results for Year ended December 31, 2024
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 61187501
- Dividend
- 10
- Unconsolidated Pat
- 6536047
- Bonus
- 0
- Unconsolidated Quarter Eps
- 20.52
- Ex Date
- 2025-04-21
- Right Price
- 0
- Book Closure Dates
- 2025-04-22 - 2025-04-28